Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infection.
about
Malaria vaccine research and development: the role of the WHO MALVAC committeeSerologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax.Murine immune responses to a Plasmodium vivax-derived chimeric recombinant protein expressed in Brassica napus.Immunoglobulin A Nephropathy and Malaria falciparum Infection; a Rare Association.N-terminal Plasmodium vivax merozoite surface protein-1, a potential subunit for malaria vivax vaccine.MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines.Effects of supportive-expressive group therapy in breast cancer patients with affective disorders: a pilot study.
P2860
Q33611463-38024E7F-458B-464F-ABCC-FAF778223641Q34091277-95FDFCCA-696C-4D69-A9CD-F6E2C9E3E00BQ34995142-49A1326E-19CC-448B-86AC-C7C5FD635BE0Q36934519-0A962829-F43E-4126-B594-E436973B2107Q38159694-2B581D82-7CF5-4817-97BD-B22FAA203E42Q42406773-EB34C1BB-E5B6-427B-BADC-361998911A37Q47334799-F4F55718-46F6-4A74-B4EB-F91E578C5C6F
P2860
Guidance on the evaluation of Plasmodium vivax vaccines in populations exposed to natural infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Guidance on the evaluation of ...... exposed to natural infection.
@en
Guidance on the evaluation of ...... exposed to natural infection.
@nl
type
label
Guidance on the evaluation of ...... exposed to natural infection.
@en
Guidance on the evaluation of ...... exposed to natural infection.
@nl
prefLabel
Guidance on the evaluation of ...... exposed to natural infection.
@en
Guidance on the evaluation of ...... exposed to natural infection.
@nl
P2860
P50
P1433
P1476
Guidance on the evaluation of ...... exposed to natural infection.
@en
P2093
Vasee S Moorthy
WHO Malaria Vaccine Advisory Committee (MALVAC)
P2860
P304
P356
10.1016/J.VACCINE.2009.07.018
P407
P577
2009-07-26T00:00:00Z